CLC Number: 

  • R737.11
[1] Chu MS. Hemangioma in Renal Pelvis[J]. Kosin Medical Journal, 2021, 36(2): 175-179.
[2] Yu H, Sun W, Zhang J. Radiological features of renal pelvic hemangioma: a case series[J]. Transl Androl Urol, 2021, 10(10): 3766.doi: 10.21037/tau-21-489.
[3] Omiyale AO. Primary vascular tumours of the kidney[J]. World J Clin Oncol, 2021, 12(12): 1157.doi: 10.5306/wjco.v12.i12.1157.
[4] Chandran N, Kannan MS, Veeramani M. Renal anastomosing hemangioma: a diagnosis to ponder[J]. Indian Journal of Transplantation, 2019, 13(1): 59.doi: 10.4103/ijot.ijot_63_18.
[5] 薛晓丽, 邵硕, 郑宁. 肾盂黏膜下海绵状血管瘤误诊一例并文献复习[J].磁共振成像, 2021, 12(4): 82-83. XUE Xiaoli, SHAO Shuo, ZHENG Ning. Misdiagnosis of submucosal cavernous hemangioma of renal pelvis: a case report and literature review[J]. Chinese Journal of Magnetic Resonance Imaging, 2021, 12(4): 82-83.
[6] Brown JG, Folpe AL, Rao P, et al. Primary vascular tumors and tumor-like lesions of the kidney: a clinicopathologic analysis of 25 cases[J]. Am J Surg Pathol, 2010, 34(7): 942-949.
[7] Bui TL, Glavis-Bloom J, Liu HK, et al. Multiple renal capillary hemangiomas in a patient with end-stage renal disease[J]. Radiol Case Rep, 2019, 14(6): 750-754.
[8] Chen T, Jin P, Wang Y, et al. Renal cavernous hemangioma in a child: case report and review of the literature[J]. Urology, 2011, 78(5): 1185-1186.
[9] Geramizadeh B, Shams N, Iranpour P, et al. Renal capillary hemangioma mimicking urothelial carcinoma, a case report and review of the literature[J]. Iran J Pathol, 2019, 14(2): 175. doi: 10.30699/IJP.14.2.175.
[10] Lo C, Cheng S. Case Report on Anastomosing Haemangioma: an unusual vascular tumor in kidney[J]. Case Rep Nephrol, 2021, 2021.doi: 10.1155/2021/8847998.
[11] Cheon PM, Rebello R, Naqvi A, et al. Anastomosing hemangioma of the kidney: radiologic and pathologic distinctions of a kidney cancer mimic[J]. Curr Oncol, 2018, 25(3): 220-223.
[12] Atre A, Unune N, Nanivadekar A, et al. Renal haemangioma-rare differential of solid renal neoplasm[J]. Eur J Radiol, 2007, 61(1): 27-29.
[13] Geenen RWF, Den Bakker MA, Bangma CH, et al. Sonography, CT, and MRI of giant cavernous hemangioma of the kidney: correlation with pathologic findings[J]. AJR Am J Roentgenol, 2004, 182(2): 411-414.
[14] Zheng LP, Shen WA, Wang CH, et al. Anastomosing hemangioma arising from the left renal vein: a case report[J]. World J Clin Cases, 2020, 8(20): 4986. doi: 10.12998/wjcc.v8.i20.4986.
[15] 周选民, 母华国, 桑玲, 等. 肾盏海绵状血管瘤的临床特征及CT、MRI影像表现[J]. 临床放射学杂志, 2017, 36(10):1468-1472. ZHOU Xuanmin, MU Huaguo, SANG Ling, et al.Clinical characteristics and CT, MRI findings of calyceal cavernous hemangioma[J]. Journal of Clinical Radiology, 2017, 36(10):1468-1472.
[16] Zhao X, Zhang J, Zhong Z, et al. Large renal cavernous hemangioma with renal vein thrombosis: case report and review of literature[J]. Urology, 2009, 73(2): 443. e1-443. e3. doi: 10.1016/j.urology.2008.02.049.
[17] Geenen RWF, Den Bakker MA, Bangma CH, et al. Sonography, CT, and MRI of giant cavernous hemangioma of the kidney: correlation with pathologic findings[J]. AJR Am J Roentgenol, 2004, 182(2): 411-414.
[18] Chandran N, Kannan MS, Veeramani M. Renal anastomosing hemangioma: a diagnosis to ponder[J]. Indian Journal of Transplantation, 2019, 13(1): 59. doi: 10.4103/ijot.ijot_63_18.
[19] Pedrosa I, Sun MR, Spencer M, et al. MR imaging of renal masses: correlation with findings at surgery and pathologic analysis[J]. Radiographics, 2008, 28(4): 985-1003.
[20] Nakamura K, Yamada Y, Rosser CJ, et al. Holmium YAG laser ablation of a hemangioma involving a lower pole renal calyx-using the new-generation flexible ureteroscope URF type P5®: a case report[J]. Cases J, 2009, 2(1): 1-3.
[1] LI Yinglin, SONG Daoqing, XU Zhonghua. Identification of FKBP11 expression in clear cell renal cell carcinoma using bioinformatics analysis [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 45-51.
[2] GAO Pei, MAO Changlin, CHEN Feng, HE Wei, GUAN Yong,LYU Jiaju, LI Shanjun, DING Sentai. Application of CT three-dimensional reconstruction modified R.E.N.A.L. score in 50 cases of laparoscopic partial nephrectomy [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 52-57.
[3] ZHAO Zuohui, LI Cuiling, WANG Daoguang, WANG Fengqin, QU Hongyi, DING Sentai, GONG Jing, LÜ Jiaju, YANG Jinghua. Effect of MnSOD acetylation on the proliferation and apoptosis of clear cell renal cell carcinoma cell line 786-O [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 31-35.
[4] SU Jing, XUE Jiaomei, SUN Feifei, GUO Zhaoxin, CHENG Xiangyu, MENG Liwei, LIU Zhaoxu. Comparison of nephron-sparing surgery and radical nephrectomy for T1b renal cell carcinoma: a Meta-analysis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(9): 65-70.
[5] XIE Fang, LIU Shuai, LIU Zheng, NIU Zhi-hong. NOV modulates expression of Ki-67,VEGF,p27 and COX-2 in renal clear cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(10): 29-32.
[6] ZHANG Bin1, CHEN Jie2, LIU Yan3, ZHANG Shi-bao2, LIU Shuang-qing2, LIU Bo2,WANG Quan-ying4, YANG Guang-xiao4, LIU Qing-yong2. Anti-tumor effect of recombinant adeno-associated virus mediated secretive expression of renal cell carcinoma suppressor fusion peptide on chick embryo implanted tumors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 33-36.
[7] XIONG Hui1, XIA Ting2, JIANG Shaobo1, XIA Qinghua1, ZHAO Yong1, JIN Xunbo1. Effect of the renal volume on surgical occasion for patients with  autosomal dominant polycystic kidney disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(8): 96-99.
[8] TIAN Su-jian1, CHENG Li2, XU Zhong-hua1, REN Ju-chao1, LI Da-wei1, LIU Hai-nan1. Relationship of renal cell carcinoma angiogenesis with heparanase and cyclooxygenase-2 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(7): 135-139.
[9] LIU Hai-nan1,2, LI Da-wei2, ZHANG Jian-ping3, REN Ju-chao2, TIAN Su-jian2, FANG Zhi-qing2, L Jia-ju1. Expression and clinical significance of HepaCAM expression in  renal clear cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 81-84.
[10] Lv Yi-jing, REN Min, WANG Bo, GE Ru-qing, ZHANG Ji-dong. Expressions of CTGF and EZH2 in renal clear cell carcinoma  and their clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 85-89.
[11] LIU Hai-nan1,2, LI Da-wei2, ZHANG Jian-ping3, REN Ju-chao2, TIAN Su-jian2, FANG Zhi-qing2, L Jia-ju1. Expression and clinical significance of HepaCAM expression in  renal clear cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 81-84.
[12] Lv Yi-jing, REN Min, WANG Bo, GE Ru-qing, ZHANG Ji-dong. Expressions of CTGF and EZH2 in renal clear cell carcinoma  and their clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 85-89.
[13] CHEN Qiang1,2, L Jiaju1, JING Tao2, LI Yujun3. Expressions of MMP-2/ CXCR4 and their clinical significance in renal clear cell carcinoma tissues [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(6): 107-.
[14] HAN Letian, DING Kejia. Expression and significance of cyclin D1, cyclin E and p27 in transitional cell carcinoma of the renal pelvis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(4): 109-112.
[15] LI Caixia, XIE Fubo, ZHANG Kai. TACE for patients with renal carcinoma and the influence on cell immune function [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(2): 121-123.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!